NCT03155412View on ClinicalTrials.gov

Adipose Tissue Expandability and Type 2 Diabetes

CompletedOBSERVATIONAL
Enrollment

44

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

March 31, 2018

Study Completion Date

January 31, 2019

Conditions
Type2 Diabetes Mellitus
Trial Locations (1)

100 00

Third Faculty of Medicine, Charles University, Prague

All Listed Sponsors
lead

Charles University, Czech Republic

OTHER

NCT03155412 - Adipose Tissue Expandability and Type 2 Diabetes | Biotech Hunter | Biotech Hunter